Research & News

HAART and Late Entry Into Prenatal HIV Care

Nov 30, 2013

Researchers found that women, both treatment experienced and treatment naive, who had greater than 50% adherence to HAART during the prenatal period were able to reduce their viral load to under 400 copies/mL in approximately 26 days.  Viral load suppression was also... Read More

Universal versus Targeted HIV Screening in Emergency Departments

Nov 30, 2013

The setting of an emergency department poses many challenges for the implementation of an HIV screening program.  While universal HIV screening is recommended, the transient population of an ED makes it hard to follow this recommendation.  Researchers developed a randomized... Read More

Cured Infant Remains HIV-Free

Nov 21, 2013

The infant born HIV-positive in Mississippi and started on ART at 30 hours of age continues to show no sign of HIV-1 infection at 30 months of age. The infant received ART for 18 months after birth. This case shows the potential for early ART initiation to effect the long-... Read More

C-Sections for HIV-Positive Women

Oct 31, 2013

Although cesarean sections are recommended for preventing perinatal HIV transmission, they are currently not recommended for those women with viral loads less than 400 copies/mL in France and less than 1000 copies/mL in the US.  The French Perinatal Cohort study looked at... Read More

Exposure to ARVs In Utero and Language Delays

Oct 31, 2013

Researchers from the Pediatric HIV/AIDS Cohort Study found no association with exposure to ARVs in utero and language delays for HIV-exposed but negative children overall.  However, in utero exposure to atazanavir showed increased odds of language delays for one-year olds... Read More

Current Usefulness of Intrapartum AZT for Perinatal HIV Transmission Prevention

Sep 30, 2013

The French Perinatal Cohort study looked at women delivering between 1997-2010 to detemine the usefulness of intrapartum AZT when a mother receives HAART during pregnancy.  Usage of intrapartum AZT was over 95%.  Lack of intrapartum AZT was associated with older age,... Read More

Use of Raltegravir to Prevent Perinatal Transmission

Sep 30, 2013

This case report illustrates the use of raltegravir for viral load supression late in pregnancy.  Although safety and pharmacokinetic data are not available for the use of raltegravir in pregnant women, it has been used in limited cases where the patient has multidrug... Read More

HIV-Positive Women and High Rates of Intimate Partner Violence

Sep 30, 2013

Women have a higher risk of HIV infection when affected by intimate partner violence.  In addition, high rates of intimate partner violence amongst HIV-positive women have been linked to poorer health outcomes, including less engagement in HIV care.  Providers should work... Read More

Perinatal HIV Elimination in High Resource Settings

Sep 12, 2013

While much of the focus on elimination of mother-to-child transmission of HIV has been in low resource settings, there is still work to be done in high resource settings. As women are living longer with the help of ART, more HIV-positive women are having children. Providers... Read More

Transfer of ARVs In Utero versus Via Breastfeeding

Aug 31, 2013

Researchers measured levels of ARVs, including lopinavir, ritonavir, and efavirenz, in infants via samples of hair, plasma, and cord blood as well as mother's breastmilk to determine methods of transfer to infants.  Levels were measured at various times postpartum. ... Read More

Pages